Organization and Basis of Presentation (Details) $ in Thousands |
1 Months Ended | 9 Months Ended | |||
---|---|---|---|---|---|
Dec. 31, 2021
USD ($)
|
Mar. 31, 2019
USD ($)
|
Sep. 30, 2023
USD ($)
Program
item
|
Sep. 30, 2022
USD ($)
|
Dec. 31, 2022
USD ($)
|
|
Principal Business Activity [Line Items] | |||||
Number of programs in clinical development | Program | 6 | ||||
Number of distinct areas of unmet medical need | item | 3 | ||||
Accumulated deficit | $ (574,446) | $ (470,204) | |||
Cash flows from operations | (90,818) | $ (56,831) | |||
Cash, cash equivalents | $ 137,703 | $ 64,403 | $ 114,706 | $ 115,516 | |
Janssen Pharmaceuticals Inc | Collaboration Agreement | |||||
Principal Business Activity [Line Items] | |||||
Collaboration agreement upfront payment | $ 100,000 | ||||
Milestone payments | $ 30,000 | ||||
Minimum | |||||
Principal Business Activity [Line Items] | |||||
Offsetting expense, period | 12 months |
X | ||||||||||
- Definition Collaboration agreement upfront payment. No definition available.
|
X | ||||||||||
- Definition The amount of milestone payment received. No definition available.
|
X | ||||||||||
- Definition N/A No definition available.
|
X | ||||||||||
- Definition N/A No definition available.
|
X | ||||||||||
- Definition Offsetting expense period. No definition available.
|
X | ||||||||||
- Definition Schedule Of Description Of Business [Line Items] No definition available.
|
X | ||||||||||
- Definition Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of accumulated undistributed earnings (deficit). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|